Page last updated: 2024-10-25

deferiprone and Benign Paroxysmal Peritonitis

deferiprone has been researched along with Benign Paroxysmal Peritonitis in 1 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Research Excerpts

ExcerptRelevanceReference
"Herein we present a 7-year-old beta-thalassemia major patient who developed severe Henoch-Schönlein purpura (HSP) with renal, pulmonary involvement and invagination while under iron chelation with deferiprone."3.74Severe Henoch-Schönlein purpura in a thalassemic patient under deferiprone treatment. ( Besbas, N; Gücer, S; Gümrük, F; Kale, G; Ozen, S; Unal, S, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Unal, S1
Gücer, S1
Kale, G1
Besbas, N1
Ozen, S1
Gümrük, F1

Other Studies

1 other study available for deferiprone and Benign Paroxysmal Peritonitis

ArticleYear
Severe Henoch-Schönlein purpura in a thalassemic patient under deferiprone treatment.
    American journal of hematology, 2008, Volume: 83, Issue:2

    Topics: Amino Acid Substitution; beta-Thalassemia; Child; Deferiprone; DNA; Familial Mediterranean Fever; Hu

2008